# Gilead Sciences, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/gilead-sciences-inc/05c4ed0b-5c05-4c0e-996e-9e344fef905c

> Inspection records and compliance data for Gilead Sciences, Inc. in Foster City, California. Access full analysis and detailed observations.

---

## Details

- Name: Gilead Sciences, Inc.
- FEI Number: 1000523075
- City: Foster City
- State: California
- Country Name: United States
- Address Line 1: 333 Lakeside Dr
- Zip Code: 94404
- Facility Type: Manufacturer

## Related Documents

- [483 - Gilead Sciences, Inc. - Unknown Date](https://www.keypedia.com/records/483/gilead-sciences-inc/b48d7486-8192-41f4-8c73-b357f29d663d) — source: FDA, date: Invalid Date
- [CRL - Gilead Sciences, Inc. - Unknown Date](https://www.keypedia.com/records/crl/gilead-sciences-inc/72a781e8-af07-40d3-9619-cd73a63e56d8) — source: FDA, date: Invalid Date
- [FDA Inspection 1300496 - Gilead Sciences, Inc. - 2026-01-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/5929295f-e25e-484f-9dc1-296b80be96f0) — source: FDA, date: January 16, 2026
- [FDA Inspection 1300496 - Gilead Sciences, Inc. - 2026-01-16](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/d3db75e6-f2e4-4076-bd64-7e5ef2fd86dd) — classification: No Action Indicated (NAI), source: FDA, date: January 16, 2026
- [FDA Inspection 1258330 - Gilead Sciences, Inc. - 2025-01-29](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/fe311bf5-631b-4491-9c5e-f31838502b8f) — source: FDA, date: January 29, 2025
- [FDA Inspection 1258330 - Gilead Sciences, Inc. - 2025-01-29](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/dbdc0e3e-6f75-4d2e-a2df-a091f1eedd2c) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2025
- [483 - Gilead Sciences, Inc. - 2024-01-22](https://www.keypedia.com/records/483/gilead-sciences-inc/450911dd-b16c-4d24-9f1f-d8db6731ac1f) — source: FDA, date: January 22, 2024
- [FDA Inspection 1227801 - Gilead Sciences, Inc. - 2024-01-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/83ee39e1-a76c-424b-a9e1-f1575491e17e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2024
- [FDA Inspection 1128174 - Gilead Sciences, Inc. - 2020-08-18](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/affa7812-ab65-42ac-a157-78c538e9ac4f) — classification: No Action Indicated (NAI), source: FDA, date: August 18, 2020
- [483 - Gilead Sciences, Inc. - 2020-07-22](https://www.keypedia.com/records/483/gilead-sciences-inc/9e0555b0-3c5e-4b85-9607-53ee62563b81) — source: FDA, date: July 22, 2020
- [FDA Inspection 1125580 - Gilead Sciences, Inc. - 2020-07-22](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/7f61bbbc-bccb-4fea-97ef-3d2561b789f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2020
- [FDA Inspection 1086848 - Gilead Sciences, Inc. - 2019-04-04](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/0e18a779-d1a7-4a36-b8f8-51ef1109afd6) — classification: No Action Indicated (NAI), source: FDA, date: April 4, 2019
- [483 - Gilead Sciences, Inc. - 2018-07-17](https://www.keypedia.com/records/483/gilead-sciences-inc/6e644d94-ebcd-4830-b63d-611baa563e49) — source: FDA, date: July 17, 2018
- [FDA Inspection 1065316 - Gilead Sciences, Inc. - 2018-07-17](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/8f4088fc-9cb2-4dc1-ab52-b384dafafd57) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 17, 2018
- [FDA Inspection 975309 - Gilead Sciences, Inc. - 2016-05-11](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/1f2a6cdb-6a5e-4139-a52b-780667d811a3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2016
- [483 - Gilead Sciences, Inc. - 2013-04-26](https://www.keypedia.com/records/483/gilead-sciences-inc/1668a78c-7b58-4b65-bc78-75deefa4d1b1) — source: FDA, date: April 26, 2013
- [483 - Gilead Sciences, Inc. - 2011-10-18](https://www.keypedia.com/records/483/gilead-sciences-inc/a5e41bd2-9af6-4c95-861c-759948bdb5c9) — source: FDA, date: October 18, 2011

## Related Companies

- [Fresenius Kabi USA, LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/1fd32611-ab9e-438a-9ee6-59d3a913d3a3)
- [Eurofins EAG Materials Science LLC](https://www.keypedia.com/companies/eurofins-eag-materials-science-llc/95b260d4-32d3-4be9-b4db-40c9eb85a130)
- [ACTA Laboratories, Inc.](https://www.keypedia.com/companies/acta-laboratories-inc/215a2fac-a2d0-4b2e-b8ca-8c9abe4cbb7d)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Helmut-Vetter-Strasse)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-helmut-vetter-strasse/447d2af0-9c51-4d9f-a3f4-6aee290cf97a)
- [Pharmaron Lab Services LLC](https://www.keypedia.com/companies/pharmaron-lab-services-llc/9e4d9585-b814-46c1-bbff-42a9b5abee96)
- [Chiesi Farmaceutici S.p.A.](https://www.keypedia.com/companies/chiesi-farmaceutici-spa/c5c5e25e-4e01-482a-b5b3-7a7b11458a67)
- [Gram Laboratories Inc](https://www.keypedia.com/companies/gram-laboratories-inc/f54a2075-d931-4c44-a97c-e63f05375d9a)
- [Nexus Pharmaceuticals, LLC](https://www.keypedia.com/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf)
- [BioPharmaDev Inc](https://www.keypedia.com/companies/biopharmadev-inc/dd08df49-c192-4baa-88ba-19b099a2ce2c)
- [Sucampo Pharma, LLC](https://www.keypedia.com/companies/sucampo-pharma-llc/0b5bf906-e2c7-4686-90c6-2d9b7c7550f9)

## Related Officers

- [Scott N. Lim](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)
- [Cynthia J. Tsui](https://www.keypedia.com/people/cynthia-j-tsui/e02b5fd2-e90b-47a7-bbc2-e658f160c4ae)
- [Grace Gill, PharmD](https://www.keypedia.com/people/grace-gill-pharmd/cfa55dee-64bb-4a80-9566-d900d4568406)
- [issuing_officer](https://www.keypedia.com/people/arindam-dasgupta/4337d565-c1cb-4a78-aeae-f5afc35644d8)
- [Kevin P. Foley](https://www.keypedia.com/people/kevin-p-foley/66aed833-31fa-4ae9-bcfd-b266b957642c)